Cardiomyopathy Trial, Recruiting NCT05521451 Sponsor: Universitätsklinikum Hamburg-Eppendorf Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT05521451
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a heart rhythm disorder (including one present from birth) that has already been diagnosed, or who have been identified as being at high risk of developing a heart rhythm disorder
  • People who are 18 years of age or older
  • People who are willing and able to give written agreement to participate in the study

Who may not be able to join:

  • People who do not have enough knowledge of the German language to understand the study documents and take part in interviews without the need for translation
  • People who, for physical or mental health reasons, are not able to fully participate in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Paulus Kirchhof, MD, Universitätsklinikum Hamburg-Eppendorf

Phone: +49 (40) 7410 - 58320

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Registry
ClinicalTrials.gov
Start date
17 March 2021
Est. completion
30 September 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Time to a composite of cardiovascular mortality, stroke, acute coronary syndrome and heart failure hospitalization; New onset of cardiac arrhythmias, documented in clinical care and during systematic rhythm monitoring using digital devices.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov